// App-Quantinova.ai

: CO43923: A Platform Study Evaluating the Safety and Efficacy of Multiple Treatment Combinations in Patients with Multiple Myeloma

Researchers

Presenter

  • Semira Sheikh

Principal Investigators

  • Upen Patil

  • Kristin Wehrman

  • Elissavet Sideri

  • Shannon M. Ruppert

  • Yanke Yu

  • Mark Yan

  • Jasdeep Bhatti

  • Lydia Pogeza

  • Yann Nouet

Medical Centers

  • N/A

Locations

  • Canada

  • United States

  • Switzerland

  • United Kingdom

Companies

  • Genentech, Inc.

  • F. Hoffmann-La Roche

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 2AP

Drug/Treatment

  • Lenalidomide

Outcome

  • N/A

Study Design

  • Randomized

  • Efficacy

  • Safety

  • Non Interventional

  • Single Arm

  • Dose Escalation

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved